Documentation should include symptom history, ankle-brachial index (ABI) results if available, imaging if available, and an ICD-10 code (often I70.21 or I73.9)
Adding fatty acid chains or polyethylene glycol to a peptide increases its stability and prevents the digestive system from breaking it down too quickly [2]
The high cost and growing demand for weight-loss medications like Wegovy (semaglutide) have led to increased interest in insurance coverage for the drug
Participants were randomized 1:1 to semaglutide or placebo
History of medullary thyroid cancer or MEN2 Pregnancy or breastfeeding Severe GI disorders (gastroparesis) Certain endocrine conditions Allergy to GLP-1 medications Appetite reduction begins within the first 12 weeks
Intranasal delivery represents the most significant methodological advancement because it bypasses hepatic first-pass metabolism entirely, but technique sensitivity (nasal cavity anatomy, administration volume, head positioning post-dose) introduces reproducibility challenges that subcutaneous injection avoids